Add like
Add dislike
Add to saved papers

Hexadecyltrimethylammonium bromide (CTA-Br) and 1-butyl-3-methylimidazolium tetrafluoroborate (bmim-BF 4 ) in aqueous solution: An ephemeral binary system.

HYPOTHESIS: Mixtures of the cationic surfactant hexadecyltrimethylammonium bromide (CTA-Br) and the ionic liquid 1-butyl-3-methylimidazolium tetrafluoroborate (bmim-BF4 ) in aqueous solutions are expected to behave as typical binary cationic surfactant system taking into account the surface activity displayed by the ionic liquid, instead of considering the IL as a water cosolvent.

EXPERIMENTS: Surface tension and conductivity measurements have been conducted as a function of the total concentration of the mixtures at different surfactant mole fraction (αCTA-Br ) to investigate the surface active properties.

FINDINGS: Turbidity immediately appearing when the compounds are mixed in water suggests the spontaneous formation of the low soluble compound hexadecyltrimethylammonium tetrafluoroborate (CTA-BF4 ), together with the salt formed by the respective counterions bmim+ and Br- in solution. For αCTA-Br ≠0.5, furthermore of the mentioned compounds, the spare bmim-BF4 (for αCTA-Br <0.5) or CTA-Br (for αCTA-Br >0.5), are also present in the aqueous solution. Systems containing excess of bmim-BF4 show a low critical aggregate concentration (cac), but an unexpected high surface tension at cac (γcac ≈53-56mN/m), as pure CTA-BF4 . For systems containing excess of CTA-Br, cac increases but γcac decreases up to 36mN/m. Mixtures of pure CTA-BF4 and bmim-BF4 or CTA-Br behave as typical binary surfactant systems.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app